WHWK News

Whitehawk Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

MORRISTOWN, N.J., Aug. 7, 2025 /PRNewswire/ -- Whitehawk Therapeutics, Inc. (Nasdaq: WHWK), an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved ADC cancer treatments, today announced financial results for the second...

August 7, 2025Earnings

Whitehawk Therapeutics Q1 EPS $1.83 Beats $(0.46) Estimate, Sales $7.14M Up From $5.35M YoY

WHWK

May 8, 2025